Compare SHRI CHLOCHEM with - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ARCHIT ORGANOSYS vs TATVA CHINTAN PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ARCHIT ORGANOSYS TATVA CHINTAN PHARMA ARCHIT ORGANOSYS/
TATVA CHINTAN PHARMA
 
P/E (TTM) x 11.4 - - View Chart
P/BV x 2.2 33.6 6.4% View Chart
Dividend Yield % 0.0 0.0 -  

Financials

 ARCHIT ORGANOSYS   TATVA CHINTAN PHARMA
EQUITY SHARE DATA
    ARCHIT ORGANOSYS
Mar-21
TATVA CHINTAN PHARMA
Mar-21
ARCHIT ORGANOSYS/
TATVA CHINTAN PHARMA
5-Yr Chart
Click to enlarge
High Rs27NA-   
Low Rs5NA-   
Sales per share (Unadj.) Rs62.9149.5 42.1%  
Earnings per share (Unadj.) Rs3.326.0 12.8%  
Cash flow per share (Unadj.) Rs5.829.4 19.7%  
Dividends per share (Unadj.) Rs00-  
Avg Dividend yield %0NM- 
Book value per share (Unadj.) Rs26.182.6 31.6%  
Shares outstanding (eoy) m15.0220.09 74.8%   
Bonus / Rights / Conversions ---  
Price / Sales ratio x0.30-   
Avg P/E ratio x4.90-  
P/CF ratio (eoy) x2.80-  
Price / Book Value ratio x0.60-  
Dividend payout %00-   
Avg Mkt Cap Rs m2440-   
No. of employees `000NANA-   
Total wages/salary Rs m61241 25.3%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m9453,004 31.5%  
Other income Rs m559 9.2%   
Total revenues Rs m9513,063 31.0%   
Gross profit Rs m111659 16.8%  
Depreciation Rs m3767 54.5%   
Interest Rs m3344 73.1%   
Profit before tax Rs m47607 7.7%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m-384 -3.8%   
Profit after tax Rs m50523 9.6%  
Gross profit margin %11.722.0 53.3%  
Effective tax rate %-6.913.9 -49.5%   
Net profit margin %5.317.4 30.4%  
BALANCE SHEET DATA
Current assets Rs m3451,843 18.7%   
Current liabilities Rs m3461,180 29.3%   
Net working cap to sales %-0.122.1 -0.5%  
Current ratio x1.01.6 63.9%  
Inventory Days Days50 1,385.1%  
Debtors Days Days966110 875.7%  
Net fixed assets Rs m5191,306 39.8%   
Share capital Rs m150201 74.8%   
"Free" reserves Rs m2411,459 16.6%   
Net worth Rs m3921,660 23.6%   
Long term debt Rs m121268 45.3%   
Total assets Rs m8643,148 27.4%  
Interest coverage x2.414.6 16.7%   
Debt to equity ratio x0.30.2 191.8%  
Sales to assets ratio x1.11.0 114.6%   
Return on assets %9.618.0 53.0%  
Return on equity %12.831.5 40.6%  
Return on capital %15.533.8 45.8%  
Exports to sales %11.90-   
Imports to sales %00-   
Exports (fob) Rs m112NA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m1120-   
Fx outflow Rs m00-   
Net fx Rs m1120-   
CASH FLOW
From Operations Rs m111243 45.7%  
From Investments Rs m-29-210 13.6%  
From Financial Activity Rs m-74-88 83.8%  
Net Cashflow Rs m9-55 -15.7%  

Share Holding

Indian Promoters % 57.4 79.2 72.5%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.0 10.9 -  
FIIs % 0.0 3.5 -  
ADR/GDR % 0.0 0.0 -  
Free float % 42.6 20.8 204.5%  
Shareholders   7,734 89,438 8.6%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ARCHIT ORGANOSYS With:   PAUSHAK.  MAHICKRA CHEMICALS  GFL  SEYA INDUSTRIES  LIME CHEM  



Today's Market

Bloodbath on Dalal Street: 6 Reasons Why Sensex Slumped 1,688 Points Today(Closing)

Indian share markets witnessed negative trading activity throughout the day today and ended deep in the red.

Related Views on News

Shares of Oxygen Suppliers in Focus Amid Rising Demand for Oxygen (Company Info)

Apr 20, 2021

In this article, we discuss the hype around Oxygen supplier stocks and a little known NBFC company, which has rallied 150% in less than a month.

Nazara Technologies IPO: Should You Apply? (IPO)

Mar 17, 2021

Should you bet on this gaming company backed by ace investor Rakesh Jhunjhunwala?

Shares of Oxygen Suppliers in Focus Amid Rising Demand for Oxygen (Company Info)

Apr 20, 2021

In this article, we discuss the hype around Oxygen supplier stocks and a little known NBFC company, which has rallied 150% in less than a month.

Nazara Technologies IPO: Should You Apply? (IPO)

Mar 17, 2021

Should you bet on this gaming company backed by ace investor Rakesh Jhunjhunwala?

More Views on News

Most Popular

Infosys vs TCS: Which is Better?(Views On News)

Nov 26, 2021

In the post pandemic era, the top two IT companies in India are fighting to capture the growing demand for IT.

This Multibagger Stock Zooms 20% After Dolly Khanna Buys Stake(Views On News)

Nov 24, 2021

Shares of this edible oil company zoomed over 50% in three days after ace investor bought around 1% stake.

How to Hit Rs 100 Crore Wealth in Your Lifetime(Equitymaster Wealth)

Nov 15, 2021

This is how you can achieve the ambitious goal of a net worth of Rs 100 crore.

Don't Sell these Stocks if the Market Falls(Profit Hunter)

Nov 17, 2021

These are the 3 types of stocks that you should not sell in a market crash.

MobiKwik IPO Opens for Subscription Soon. Key Things to Know Before Subscribing.(Views On News)

Nov 20, 2021

The Rs 19 bn issue is set to hit the market soon.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

ARCHIT ORGANOSYS SHARE PRICE


Nov 26, 2021 (Close)

TRACK ARCHIT ORGANOSYS

  • Track your investment in ARCHIT ORGANOSYS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ARCHIT ORGANOSYS

ARCHIT ORGANOSYS 8-QTR ANALYSIS

COMPARE ARCHIT ORGANOSYS WITH

MARKET STATS